Angioimmunoblastic T-cell lymphoma screening: Difference between revisions
Created page with "__NOTOC__ {{Angioimmunoblastic T-cell lymphoma}} Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing..." |
Category |
||
| (2 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Angioimmunoblastic T-cell lymphoma}} | {{Angioimmunoblastic T-cell lymphoma}} | ||
{{CMG}}; {{AE}} {{AS}} | |||
==Overview== | |||
According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for angioimmunoblastic T-cell lymphoma. | |||
==Screening== | |||
According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for angioimmunoblastic T-cell lymphoma.<ref> Recommendations. U.S Preventive Services Task Force. http://www.uspreventiveservicestaskforce.org/BrowseRec/Search?s=angioimmunoblastic+T-cell+lymphoma Accessed on November 27, 2015</ref> | |||
==References== | ==References== | ||
{{ | {{Reflist|2}} | ||
{{WH}} | |||
{{WS}} | |||
[[Category:Disease]] | |||
[[Category:Pathology]] | |||
[[Category:Hematology]] | [[Category:Hematology]] | ||
[[Category: | [[Category:Up-To-Date]] | ||
[[Category:Oncology]] | [[Category:Oncology]] | ||
[[Category: | [[Category:Medicine]] | ||
[[Category: | [[Category:Hematology]] | ||
[[Category:Immunology]] | |||
Latest revision as of 03:22, 24 October 2017
|
Angioimmunoblastic T-cell lymphoma Microchapters |
|
Differentiating Angioimmunoblastic T-cell lymphoma from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Angioimmunoblastic T-cell lymphoma screening On the Web |
|
American Roentgen Ray Society Images of Angioimmunoblastic T-cell lymphoma screening |
|
Directions to Hospitals Treating Angioimmunoblastic T-cell lymphoma |
|
Risk calculators and risk factors for Angioimmunoblastic T-cell lymphoma screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [2]
Overview
According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for angioimmunoblastic T-cell lymphoma.
Screening
According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for angioimmunoblastic T-cell lymphoma.[1]
References
- ↑ Recommendations. U.S Preventive Services Task Force. http://www.uspreventiveservicestaskforce.org/BrowseRec/Search?s=angioimmunoblastic+T-cell+lymphoma Accessed on November 27, 2015